Evidence map›Paper›PMID 39677163›Full record

ArticleCureus2024

Analysis of Trends and Influencing Factors of Cytokine-Adsorbing Therapies: A Nationwide Ecological Study in Japan.

Shohei Ono, Keiki Shimizu

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shohei OnoDepartment of Anesthesiology and Critical Care, Jichi Medical University, Saitama Medical Center, Saitama, JPN.
Keiki ShimizuDepartment of Emergency and Critical Care Medicine, Tokyo Metropolitan Tama Medical Center, Tokyo, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCytokine-adsorption therapy has garnered attention as a potential treatment for conditions such as sepsis, although supporting evidence remains limited. Consequently, its utilization is expected to vary significantly across regions. To date, no ecological studies have investigated this regional heterogeneity.

objectiveThis study aimed to examine temporal trends in the use of continuous renal replacement therapy (CRRT) with cytokine-adsorbing hemofilters and polymyxin-B immobilized fiber-direct hemoperfusion (PMX-DHP), as well as the spatial distribution of both across Japan's 47 prefectures.

methodsThis ecological study analyzed National Database (NDB) open data. A longitudinal analysis from 2016 to 2022 assessed temporal trends in the use of adsorption membranes. A cross-sectional analysis of the 2022 data utilized Moran's I statistic to evaluate the spatial autocorrelation of adsorption therapy. To examine the relationship between the two types of adsorption therapy, we calculated the Pearson correlation coefficient and conducted a multivariate analysis.

resultsThe longitudinal analysis revealed no significant change in the proportion of cytokine-adsorbing hemofilter use, while PMX-DHP use showed a decreasing trend over the seven-year period. Cross-sectional analysis indicated spatial autocorrelation for both PMX-DHP (Moran's I: 0.34, P < 0.001) and cytokine-adsorption filter use (Moran's I: 0.24, P < 0.001). Univariate analysis (R = -0.29, P = 0.0453) and multivariate analysis (estimated coefficient: 1.27, 95% CI: 0.06-2.49, P = 0.045) demonstrated that higher usage rates of cytokine-adsorbing blood filters were associated with higher PMX-DHP usage rates.

conclusionsThis study identified a declining trend in PMX-DHP use and an association between PMX-DHP and cytokine-adsorbing hemofilter utilization. These findings suggest that physicians' preferences and perceptions regarding cytokine-adsorption therapy may influence its use. Further research with individual patient data is warranted to confirm these findings.

Indexed as

an69stcontinuous renal replacement therapyecological studyhemoadsorptionndb open datapmx-dhpsepxiris○r

Identifiers

PMID39677163
PMCPMC11638017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.